Effect on the 24-hour diurnal curve of intraocular pressure of a fixed ratio combination of timolol 0.5% and pilocarpine 2% in patients with COAG not controlled on timolol 0.5%.
نویسندگان
چکیده
Eight patients with chronic open-angle glaucoma who had an intraocular pressure greater than 24 mm Hg at some time during the day while taking timolol 0.5% twice daily were given the fixed ratio combination of timolol 0.5% with pilocarpine 2% (TP2) twice daily. By comparing full 24-hour diurnal curves on timolol with those on TP2 it was possible to show that all patients except one (at a single timepoint) had an IOP less than 22 mm Hg when changed to TP2. The mean IOPs, the area under the diurnal pressure curve, and the diurnal variation were all significantly lower on TP2 twice daily than on timolol 0.5% twice daily.
منابع مشابه
A study of replacement of timolol-pilocarpine with latanoprost in pseudoexfoliation glaucoma.
The aim of the study was to evaluate the efficacy of replacing current dual local therapy (timolol and pilocarpine) with latanoprost 0.005% in 71 pseudoexfoliation glaucoma patients with controlled intraocular pressure (IOP). 39 patients switched to latanoprost 0.005%) and 32 patients continued timolol-pilocarpine therapy. Mean diurnal (IOP) was measured at baseline, after 0.5, 1, 3 and 6 month...
متن کاملEffect of latanoprost/timolol and dorzolamide/tiomolol on intraocular pressure after phacoemulsification surgery.
AIM To evalaute the effect of fixed-combination latanoprost 0.005%/timolol maleate 0.5% and dorzolamide hydrochloride 2%/timolol maleate 0.5% on postoperative intraocular pressure after phacoemulsification cataract surgery. METHODS This study is a prospective, randomized, double-masked and placebo-controlled. The study included 90 eyes of 90 patients which were scheduled to have phacoemulsifi...
متن کاملCurrent Preferred Agents: BETAXOLOL, BRIMONIDINE (ALPHAGAN AND ALPHAGAN P), BRINZOLAMIDE (AZOPT), CARTEOLOL. DORZOLAMIDE/TIMOLOL, LATANOPROST, PILOCARPINE GEL AND DROPS, and TRAVOPROST (TRAVATAN Z®). Current Non-preferred Agents: ACETAZOLAMIDE, ACETYLCHOLINE CHLORIDE (MIOCHOL-E), ALPHAGAN® P, ALPRACLONIDINE (IOPIDINE), AZOPT®, BETAXOLOL
Background: The first goal of medical therapy in glaucoma is to reduce intraocular pressure (IOP), and the fixed-combination medications are needed to achieve sufficiently low target IOP. The aim of this systematic review and meta-analysis is to evaluate IOP-lowering effect of the commonly used fixed-combination drugs containing 0.5% timolol. Methods: Pertinent publications were identified thro...
متن کاملمقایسه تاثیر تیمولول و بتاکسولول بر کاهش فشار داخل چشمی و عوارض موضعی و سیستمیک آنها
Background and purpose: This is a study to compare the efficacy and side effects of betaxolol and timolol in lowering the IOP of primary open angle glaucoma or ocular hypertension. Materials and Methods: This Double-blind randomized cross-over clinical trial was conducted on 29 eyes of 20 patients with primary open angle glaucoma or ocular hypertension. Each patient received timolol 0.5% a...
متن کاملLatanoprost and timolol combination therapy vs monotherapy: one-year randomized trial.
OBJECTIVE To compare the efficacy and safety of a fixed combination of 0.005% latanoprost and 0.5% timolol maleate administered once daily vs monotherapy with either 0.005% latanoprost once daily or 0.5% timolol twice daily. METHODS Patients with either primary or secondary open-angle glaucoma or ocular hypertension participated in a 6-month, randomized, double-masked, multicenter study with ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- The British journal of ophthalmology
دوره 73 10 شماره
صفحات -
تاریخ انتشار 1989